Wednesday, February 8, 2012
Bend Research Inks Deal With Eli Lilly
Bend, Oregon-based Bend Research, a provider of drug-formulation development and manufacturing services, said today that it has inked a deal with Eli Lilly and Company. According to Bend Research, it is making its proprietary spray-dried dispersion (SDD) technology to Lilly, a technology which improves the bioavailability of compounds with low aqueous solubility. Financial terms of the deal were not disclosed. Bend said the deal also gives Lilly's scientists "broad access" to its other drug delivery technologies.